Ultrasound-guided percutaneous core biopsy of thoracic lesions: Diagnostic yield and site-specific safety
US-guided percutaneous core biopsy has a high diagnostic accuracy and low complication rate. However, safety varies according to site, with serious adverse events limited to patients with lung parenchymal targets. US-guided core biopsy is a feasible first-line approach for accessible extrapulmonary thoracic lesions; however, careful consideration is required for intrapulmonary targets.
Authors
- Hiromi Ide (ORCID: https://orcid.org/0000-0001-5619-5706)
- Mitsukuni Sakabe (ORCID: https://orcid.org/0000-0001-6517-849X)
- Kohei Yoshimine
- Yuri Hiramatsu
- Minako Hanaka
- Takafumi Kawabata
- Kazunori Tobino (ORCID: https://orcid.org/0000-0002-3456-6833)
- Ryuta Yamamoto (ORCID: https://orcid.org/0000-0002-2700-1308)
- Akiko Maeda (ORCID: https://orcid.org/0000-0002-9297-945X)
- Saori Nishizawa (ORCID: https://orcid.org/0000-0002-3040-0756)
- Kazuki Uchida (ORCID: https://orcid.org/0009-0008-5966-2929)
- Ryunosuke Oi
- Yosuke Murakami
- Hiroaki Ota (ORCID: https://orcid.org/0000-0003-0361-6540)
- Shota Sogabe
Institutions
- Aso Iizuka Hospital (JP)
Publication Details
- Journal
- Respiratory Investigation
- Published
- 2025-12-06
- DOI
- https://doi.org/10.1016/j.resinv.2025.101347
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00